Symbols / BACK $0.04 +0.00% IMAC Holdings, Inc.

Healthcare • Medical Care Facilities • United States • PNK
BACK Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Ms. Faith Zaslavsky
Exch · Country PNK · United States
Market Cap 143.83K
Enterprise Value 3.93M
Income -11.57M
Sales 22.72K
FCF (ttm) -606.81K
Book/sh -3.43
Cash/sh 0.01
Employees 15
Insider 10d
IPO Feb 13, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -0.01
PEG
P/S 6.33
P/B -0.01
P/C
EV/EBITDA -0.52
EV/Sales 172.84
Quick Ratio 0.00
Current Ratio 0.02
Debt/Eq
LT Debt/Eq
EPS (ttm) -2.98
EPS next Y -3.48
EPS Growth
Revenue Growth -62.30%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2024-05-15
Earnings (prior) 2024-05-15
ROA -5.51%
ROE
ROIC
Gross Margin 0.00%
Oper. Margin -87.33%
Profit Margin 0.00%
Shs Outstand 3.78M
Shs Float 3.72M
Insider Own 1.52%
Instit Own 0.00%
Short Float 2.01%
Short Ratio 0.29
Short Interest 66.89K
52W High 0.21
vs 52W High -81.90%
52W Low 0.03
vs 52W Low 52.00%
Beta 1.70
Impl. Vol.
Rel Volume 0.00
Avg Volume 5.75K
Volume 20.00
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $0.04
Price $0.04
Change 0.00%
About

IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.04
Low
High
Mean
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-12-31 BUSCH JEFFREY M Director 3,333 $0.00 $0
2024-12-31 PRUITT MICHAEL D Director 3,333 $0.00 $0
2024-12-31 EVANS MAURICE E Director 3,333 $0.00 $0
2024-12-31 SCHWARTZ MATTHEW WILSON Director 3,333 $0.00 $0
2024-12-31 BEITSCH PETER Director 3,333 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.07
0.00
0.00
-100.00%
14.39
Operating Revenue
0.07
0.00
0.00
-100.00%
14.38
Cost Of Revenue
0.31
0.00
-100.00%
1.51
-7.36%
1.63
Reconciled Cost Of Revenue
0.31
0.00
-100.00%
1.51
-7.36%
1.63
Gross Profit
-0.23
0.00
-100.00%
14.68
+15.05%
12.76
Operating Expense
5.39
+83.23%
2.94
-59.84%
7.32
-67.75%
22.71
Selling General And Administration
5.39
+83.23%
2.94
-55.89%
6.67
-68.33%
21.06
Selling And Marketing Expense
0.01
-89.55%
0.07
-94.41%
1.32
General And Administrative Expense
5.39
+83.23%
2.94
-55.40%
6.60
-66.58%
19.73
Salaries And Wages
1.76
+30.46%
1.35
-67.35%
4.13
-68.97%
13.31
Other Gand A
5.39
+83.23%
2.94
+19.31%
2.47
-61.61%
6.42
Total Expenses
5.70
+93.61%
2.94
-59.84%
7.32
-69.90%
24.33
Operating Income
-5.62
-91.16%
-2.94
+59.84%
-7.32
+26.38%
-9.95
Total Operating Income As Reported
-5.62
+11.80%
-6.38
+46.14%
-11.84
-17.22%
-10.10
EBITDA
-5.48
+7.84%
-5.95
+41.71%
-10.20
-21.60%
-8.39
Normalized EBITDA
-5.48
-118.10%
-2.51
+55.82%
-5.69
+30.97%
-8.24
Reconciled Depreciation
0.14
-65.51%
0.40
-75.19%
1.63
-1.37%
1.65
EBIT
-5.62
+11.50%
-6.35
+46.31%
-11.83
-17.83%
-10.04
Total Unusual Items
0.00
+100.00%
-3.43
+23.91%
-4.51
-2919.58%
-0.15
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-3.43
+23.91%
-4.51
-2919.58%
-0.15
Special Income Charges
0.00
+100.00%
-3.43
+23.91%
-4.51
-2919.58%
-0.15
Net Income
-9.05
+3.96%
-9.42
+48.57%
-18.31
-73.71%
-10.54
Pretax Income
-6.30
+2.74%
-6.48
+45.27%
-11.83
-12.22%
-10.54
Net Non Operating Interest Income Expense
-0.67
-589.61%
-0.10
-1562.69%
0.01
+101.33%
-0.50
Interest Expense Non Operating
0.68
+442.53%
0.12
+3864.66%
0.00
-99.37%
0.50
Net Interest Income
-0.67
-589.61%
-0.10
-1562.69%
0.01
+101.33%
-0.50
Interest Expense
0.68
+442.53%
0.12
+3864.66%
0.00
-99.37%
0.50
Interest Income Non Operating
0.00
-87.22%
0.03
+176.00%
0.01
+241.04%
0.00
Interest Income
0.00
-87.22%
0.03
+176.00%
0.01
+241.04%
0.00
Other Income Expense
-3.44
+23.88%
-4.51
-4799.08%
-0.09
Other Non Operating Income Expenses
-0.00
-255.40%
-0.00
-101.00%
0.06
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-9.05
+3.96%
-9.42
+48.57%
-18.31
-73.71%
-10.54
Net Income From Continuing Operation Net Minority Interest
-6.30
+2.74%
-6.48
+45.27%
-11.83
-12.22%
-10.54
Net Income From Continuing And Discontinued Operation
-9.05
+3.96%
-9.42
+48.57%
-18.31
-73.71%
-10.54
Net Income Continuous Operations
-6.30
+2.74%
-6.48
+45.27%
-11.83
-12.22%
-10.54
Net Income Discontinuous Operations
-2.75
+6.63%
-2.94
+54.59%
-6.48
Normalized Income
-6.30
-107.06%
-3.04
+58.44%
-7.32
+29.59%
-10.39
Net Income Common Stockholders
-12.18
-27.54%
-9.55
+47.86%
-18.31
-73.71%
-10.54
Diluted EPS
-7.76
+8.38%
-8.47
+56.41%
-19.43
-37.80%
-14.10
Basic EPS
-7.76
+8.38%
-8.47
+56.41%
-19.43
-37.80%
-14.10
Basic Average Shares
1.57
+41.17%
1.11
+17.97%
0.94
+25.37%
0.75
Diluted Average Shares
1.57
+41.17%
1.11
+17.97%
0.94
+25.37%
0.75
Diluted NI Availto Com Stockholders
-12.18
-27.54%
-9.55
+47.86%
-18.31
-73.71%
-10.54
Depreciation Amortization Depletion Income Statement
0.13
-80.74%
0.65
-60.29%
1.65
Depreciation And Amortization In Income Statement
0.13
-80.74%
0.65
-60.29%
1.65
Gain On Sale Of PPE
0.00
+100.00%
-3.43
+23.91%
-4.51
-2919.58%
-0.15
Insurance And Claims
0.31
-4.17%
0.33
Preferred Stock Dividends
3.13
+2309.73%
0.13
Rent And Landing Fees
0.16
+31.15%
0.12
Rent Expense Supplemental
0.16
+31.15%
0.12
Line Item Trend 2023-12-31 2021-12-31
Total Assets
1.14
-95.80%
27.23
Current Assets
1.14
-87.38%
9.07
Cash Cash Equivalents And Short Term Investments
0.22
-96.89%
7.12
Cash And Cash Equivalents
0.22
-96.89%
7.12
Cash Financial
0.22
-96.89%
7.12
Receivables
0.73
-39.55%
1.21
Accounts Receivable
0.00
-100.00%
1.21
Gross Accounts Receivable
0.44
-65.95%
1.29
Allowance For Doubtful Accounts Receivable
-0.44
-442.48%
-0.08
Current Deferred Assets
0.00
-100.00%
0.19
Assets Held For Sale Current
0.10
Other Current Assets
0.09
-82.70%
0.55
Total Non Current Assets
0.00
-100.00%
18.16
Net PPE
0.00
-100.00%
7.27
Gross PPE
0.00
-100.00%
10.26
Accumulated Depreciation
-2.99
Properties
0.00
Construction In Progress
0.38
Other Properties
7.76
Leases
2.13
Goodwill And Other Intangible Assets
0.00
-100.00%
10.46
Goodwill
0.00
-100.00%
4.66
Other Intangible Assets
5.80
Non Current Deferred Assets
0.07
Non Current Prepaid Assets
0.00
-100.00%
0.36
Total Liabilities Net Minority Interest
1.90
-79.55%
9.28
Current Liabilities
1.90
-61.56%
4.93
Payables And Accrued Expenses
0.58
-76.85%
2.52
Payables
0.58
-76.85%
2.52
Accounts Payable
0.45
-82.01%
2.52
Dividends Payable
0.13
Current Debt And Capital Lease Obligation
1.75
Current Debt
0.25
Other Current Borrowings
0.25
Current Capital Lease Obligation
1.50
Current Deferred Liabilities
0.32
Current Deferred Revenue
0.32
Other Current Liabilities
1.31
+288.45%
0.34
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
4.34
Long Term Debt And Capital Lease Obligation
4.15
Long Term Debt
0.10
Long Term Capital Lease Obligation
4.05
Other Non Current Liabilities
0.19
Stockholders Equity
-0.75
-104.19%
17.95
Common Stock Equity
-0.75
-104.19%
17.95
Capital Stock
0.00
-95.60%
0.03
Common Stock
0.00
-95.62%
0.03
Preferred Stock
0.00
0.00
Share Issued
1.15
+28.18%
0.90
Ordinary Shares Number
1.15
+31.40%
0.87
Treasury Shares Number
0.00
-100.00%
0.02
Additional Paid In Capital
55.18
+19.62%
46.13
Retained Earnings
-55.94
-98.31%
-28.21
Total Equity Gross Minority Interest
-0.75
-104.19%
17.95
Total Capitalization
-0.75
-104.17%
18.06
Working Capital
-0.75
-118.21%
4.13
Invested Capital
-0.75
-104.11%
18.31
Total Debt
5.90
Capital Lease Obligations
5.55
Net Tangible Assets
-0.75
-110.04%
7.49
Tangible Book Value
-0.75
-110.04%
7.49
Derivative Product Liabilities
0.19
Notes Receivable
0.73
Preferred Stock Equity
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-3.16
-13.33%
-2.79
+72.90%
-10.29
-35.61%
-7.59
Cash Flow From Continuing Operating Activities
-0.41
-370.48%
0.15
+101.49%
-10.29
-35.61%
-7.59
Cash From Discontinued Operating Activities
-2.75
+6.63%
-2.94
Net Income From Continuing Operations
-6.30
+2.74%
-6.48
+64.64%
-18.31
-73.71%
-10.54
Depreciation Amortization Depletion
0.14
-65.51%
0.40
-75.19%
1.63
-1.37%
1.65
Depreciation
0.28
Amortization Cash Flow
0.12
Depreciation And Amortization
0.14
-65.51%
0.40
-75.19%
1.63
-1.37%
1.65
Amortization Of Intangibles
0.12
Other Non Cash Items
0.64
0.26
Stock Based Compensation
0.04
-57.35%
0.08
-81.32%
0.44
-22.09%
0.57
Asset Impairment Charge
0.00
-100.00%
3.95
-53.05%
8.42
0.00
Operating Gains Losses
1.38
+1307.46%
0.10
-34.35%
0.15
Change In Working Capital
5.07
+525.92%
0.81
+131.55%
-2.57
-886.60%
0.33
Change In Receivables
-0.03
-101.93%
1.45
+182.62%
-1.75
-676.44%
0.30
Changes In Account Receivables
-0.03
-101.93%
1.45
+182.62%
-1.75
-676.44%
0.30
Change In Prepaid Assets
0.03
-92.92%
0.47
+731.76%
0.06
+55.73%
0.04
Change In Payables And Accrued Expense
5.06
+1403.54%
-0.39
+52.66%
-0.82
-391.58%
0.28
Change In Payable
0.28
Change In Account Payable
0.28
Change In Other Working Capital
-0.39
-71.40%
-0.23
-67.13%
-0.14
Change In Other Current Assets
0.27
+47.38%
0.18
+213.44%
-0.16
Change In Other Current Liabilities
0.00
+100.00%
-0.33
0.00
+100.00%
-0.16
Investing Cash Flow
-0.38
+78.88%
-1.78
-582.85%
-0.26
+89.42%
-2.46
Cash Flow From Continuing Investing Activities
-0.38
+78.88%
-1.78
-582.85%
-0.26
+89.42%
-2.46
Net PPE Purchase And Sale
0.00
-100.00%
1.00
+484.64%
-0.26
+61.19%
-0.67
Purchase Of PPE
0.00
0.00
+100.00%
-0.33
+52.28%
-0.69
Sale Of PPE
0.00
-100.00%
1.00
+1300.56%
0.07
+192.02%
0.02
Capital Expenditure
-0.33
+56.59%
-0.76
Net Business Purchase And Sale
0.00
+100.00%
-1.72
Purchase Of Business
0.00
+100.00%
-1.72
Net Intangibles Purchase And Sale
0.00
-100.00%
0.22
0.00
+100.00%
-0.07
Purchase Of Intangibles
0.00
+100.00%
-0.07
Net Other Investing Changes
-0.38
+87.50%
-3.00
Financing Cash Flow
3.82
-5.07%
4.02
-4.17%
4.20
-71.13%
14.54
Cash Flow From Continuing Financing Activities
3.82
-5.07%
4.02
-4.17%
4.20
-71.13%
14.54
Net Issuance Payments Of Debt
1.60
+4317.20%
-0.04
+86.14%
-0.27
+93.87%
-4.46
Issuance Of Debt
1.60
0.00
0.00
Repayment Of Debt
-0.00
+95.45%
-0.04
+86.14%
-0.27
+93.87%
-4.46
Long Term Debt Issuance
0.00
Long Term Debt Payments
-0.00
+93.74%
-0.03
-44.61%
-0.02
+25.18%
-0.03
Net Long Term Debt Issuance
-0.00
+93.74%
-0.03
-44.61%
-0.02
+25.18%
-0.03
Short Term Debt Issuance
1.60
0.00
Short Term Debt Payments
0.00
+100.00%
-0.01
+95.93%
-0.25
+94.26%
-4.44
Net Short Term Debt Issuance
1.60
+15558.94%
-0.01
+95.93%
-0.25
+94.26%
-4.44
Net Common Stock Issuance
0.00
-100.00%
0.02
-99.63%
4.47
-76.47%
19.01
Changes In Cash
0.28
+152.18%
-0.54
+91.48%
-6.36
-241.40%
4.50
Beginning Cash Position
0.22
-70.98%
0.76
-89.28%
7.12
+171.31%
2.62
End Cash Position
0.50
+127.61%
0.22
-70.98%
0.76
-89.28%
7.12
Free Cash Flow
-3.16
-13.33%
-2.79
+73.74%
-10.63
-27.19%
-8.35
Interest Paid Supplemental Data
0.00
-100.00%
0.13
+815.94%
0.01
-94.06%
0.24
Income Tax Paid Supplemental Data
0.00
0.00
0.00
Common Stock Issuance
0.00
-100.00%
0.02
-99.63%
4.47
-76.47%
19.01
Issuance Of Capital Stock
2.22
-45.31%
4.06
-9.18%
4.47
-76.47%
19.01
Net Preferred Stock Issuance
2.22
-45.08%
4.04
0.00
Preferred Stock Issuance
2.22
-45.08%
4.04
0.00
Sale Of Intangibles
0.00
-100.00%
0.22
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category